Johan Smitz In Manchester, Peter Goodwin hears from MASTERCLASS chair Masoud Afnan, guest experts Johan Smitz and Richard Fleming and participant Gedis Grudzinskas about the evidence base underscoring
Johan Smitz
In Manchester, Peter Goodwin hears from MASTERCLASS chairMasoud Afnan, guest expertsJohan SmitzandRichard Flemingand participantGedis Grudzinskasabout the evidence base underscoring new recommendations for treating infertility, and at the ESHRE meeting in Barcelona fromMaria LaliotiandRichard Andersonabout follicle stimulating hormone “splice variants” and ovarian hyperstimulation, and fromAnja Pinborgon the superiority of cryo-preservation for single embryo transfer.
SPEAKERS:Johan Smitz, Free University of BrusselsRichard Fleming, Glasgow UniversityMasoud Afnan, Birmingham Women’s HospitalGedis Grudzinskas, Bridge Centre, LondonMaria Lalioti, Yale University, New Haven CTRichard Anderson, University of EdinburghAnja Pinborg, Rigshospitalet, Copenhagen, Denmark
Richard Fleming
Masoud Afnan
Maria Lalioti
Anja Pinborg
Related Episodes
Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency
Timothy Yap MD PhD MBBS selective PARP inhibitor promise in breast, ovarian, pancreatic, prostate tumors.
Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
Cora Sternberg REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 CORA STERNBERG, San Camillo and Forlanini Hospital, Rome Satraplatin could pro
